These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23294255)

  • 1. Development of new cyclic plasmin inhibitors with excellent potency and selectivity.
    Saupe SM; Leubner S; Betz M; Klebe G; Steinmetzer T
    J Med Chem; 2013 Feb; 56(3):820-31. PubMed ID: 23294255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new strategy for the development of highly potent and selective plasmin inhibitors.
    Saupe SM; Steinmetzer T
    J Med Chem; 2012 Feb; 55(3):1171-80. PubMed ID: 22276953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Cyclic Plasmin Inhibitors: From Benzamidines to Benzylamines.
    Hinkes S; Wuttke A; Saupe SM; Ivanova T; Wagner S; Knörlein A; Heine A; Klebe G; Steinmetzer T
    J Med Chem; 2016 Jul; 59(13):6370-86. PubMed ID: 27280436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors.
    Wiedemeyer SJA; Wu G; Pham TLP; Lang-Henkel H; Perez Urzua B; Whisstock JC; Law RHP; Steinmetzer T
    ChemMedChem; 2023 Mar; 18(6):e202200632. PubMed ID: 36710259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin substrate binding site cooperativity guides the design of potent peptide aldehyde inhibitors.
    Swedberg JE; Harris JM
    Biochemistry; 2011 Oct; 50(39):8454-62. PubMed ID: 21877690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of cyclohexanone and tetrahydro-4H-thiopyran-4-one 1,1-dioxide as pharmacophores for the design of peptide-based inhibitors of the serine protease plasmin.
    Xue F; Seto CT
    J Org Chem; 2005 Oct; 70(21):8309-21. PubMed ID: 16209572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.
    Dietrich W; Nicklisch S; Koster A; Spannagl M; Giersiefen H; van de Locht A
    Anesthesiology; 2009 Jan; 110(1):123-30. PubMed ID: 19104179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
    Katz BA; Luong C
    J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on the inhibition of plasmin and delta-plasmin via benzamidine derivatives.
    Alves NJ; Kline JA
    Biochem Biophys Res Commun; 2015 Feb; 457(3):358-62. PubMed ID: 25576865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.
    Sielaff F; Böttcher-Friebertshäuser E; Meyer D; Saupe SM; Volk IM; Garten W; Steinmetzer T
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4860-4. PubMed ID: 21741839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin.
    Teno N; Gohda K; Wanaka K; Tsuda Y; Sueda T; Yamashita Y; Otsubo T
    Bioorg Med Chem; 2014 Apr; 22(7):2339-52. PubMed ID: 24613052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active site-directed plasmin inhibitors: Extension on the P2 residue.
    Hidaka K; Gohda K; Teno N; Wanaka K; Tsuda Y
    Bioorg Med Chem; 2016 Feb; 24(4):545-53. PubMed ID: 26732532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
    Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight trypsin-plasmin inhibitors isolated from papain treated urinary trypsin inhibitor.
    Sumi H; Toki N; Takasugi S; Maehara S; Maruyama M; Akazawa K; Matsuo O; Mihara H
    Thromb Haemost; 1982 Feb; 47(1):14-8. PubMed ID: 7071801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
    Bhongade BA; Gouripur VV; Gadad AK
    Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity.
    Ayesa S; Lindquist C; Agback T; Benkestock K; Classon B; Henderson I; Hewitt E; Jansson K; Kallin A; Sheppard D; Samuelsson B
    Bioorg Med Chem; 2009 Feb; 17(3):1307-24. PubMed ID: 19124252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N; Moroi M; Tachiya K
    Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.